A detailed history of Sax Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sax Wealth Advisors, LLC holds 9,365 shares of PFE stock, worth $250,232. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,365
Previous 10,733 12.75%
Holding current value
$250,232
Previous $300,000 9.67%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$27.7 - $31.39 $37,893 - $42,941
-1,368 Reduced 12.75%
9,365 $271,000
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $271,115 - $317,696
10,733 New
10,733 $300,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $32,688 - $42,458
1,251 Added 17.94%
8,226 $236,000
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $33,854 - $39,573
1,055 Added 17.82%
6,975 $231,000
Q1 2023

May 05, 2023

SELL
$39.39 - $51.28 $6,459 - $8,409
-164 Reduced 2.7%
5,920 $241,000
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $24,966 - $32,591
-598 Reduced 8.95%
6,084 $311,000
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $2,188 - $2,671
50 Added 0.75%
6,682 $292,000
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $15,122 - $17,930
325 Added 5.15%
6,632 $348,000
Q1 2022

Aug 11, 2022

SELL
$45.75 - $56.69 $98,271 - $121,770
-2,148 Reduced 25.41%
6,307 $326,000
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $23,515 - $29,138
-514 Reduced 5.73%
8,455 $438,000
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $81,069 - $120,172
1,962 Added 28.0%
8,969 $530,000
Q3 2021

Dec 10, 2021

SELL
$39.25 - $50.42 $23,903 - $30,705
-609 Reduced 8.0%
7,007 $301,000
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $273,490 - $309,818
7,616 New
7,616 $298,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sax Wealth Advisors, LLC Portfolio

Follow Sax Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sax Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sax Wealth Advisors, LLC with notifications on news.